Product
Supplier
Encyclopedia
Inquiry
Home > Chemicals Market Price & Insight > Ofloxacin Market Price & Analysis > Featured News - Ofloxacin > Zhejiang East Asia Pharmaceuticals achieved operating income of 345 million yuan in the first half of 2021, down 31.91% year-on-year
— Share —

Zhejiang East Asia Pharmaceuticals achieved operating income of 345 million yuan in the first half of 2021, down 31.91% year-on-year

healthoo 2021-08-16
Zhejiang East Asia Pharmaceutical Co., Ltd. report on the performance of the first half of 2021.

Please sign in to view all content or subscribe.

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.